Impact of β-blocker treatment and nutritional status on glycemic response during exercise in patients with type 2 diabetes

Clinical and Investigative Medicine

Volumn 30, Issue 6, 2007, Pages

  Ferland, Annie ^a   Brassard, Patrice ^a   Croteau, Sara ^a   Lemieux, Simone ^b   Bergeron, Jean ^c   Lacroix, Stéphanie ^a   Fournier, Lison ^a   Poirier, Paul ^a  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLUCOSE; INSULIN;

ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG MECHANISM; EXERCISE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; OXYGEN CONSUMPTION; POSTPRANDIAL STATE; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ATENOLOL; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DIET; EXERCISE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; POSTPRANDIAL PERIOD; TREATMENT OUTCOME;

EID: 37049007863     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Herlitz J, Malmberg K. How to Improve the Cardiac Prognosis for Diabetes. Diabetes Care. 1999;22 Suppl 2:B89-B96.
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other Risk Factors, and 12-yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434-44.
3. UK Prospective Diabetes Study (UKPDS) Group. Tight Blood Pressure Control and Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317:703-13.
4. Kjekshus J, Gilpin E, Cali G, Blackey AR, Henning H, Ross J, Jr. Diabetic Patients and Beta-Blockers After Acute Myocardial Infarction. Eur Heart J. 1990;11:43-50.
5. Mills GA, Horn JR. Beta-Blockers and Glucose Control. Drug Intell Clin Pharm. 1985;19:246-51.
6. Poirier P, Mawhinney S, Grondin L, et al. Prior Meal Enhances the Plasma Glucose Lowering Effect of Exercise in Type 2 Diabetes. Med Sci Sports Exerc. 2001;33:1259-64.
7. Gaudet-Savard T, Ferland A, Broderick TL, et al, P. Safety and Magnitude of Changes of Blood Glucose Levels Following Exercise Performed in the Fasted and the Postprandial State in Type 2 Diabetes Men. Eur J Cardiovasc Prev Rehab. 2007 (in press).
8. Ferland A, Brassard P, Poirier P. Is Aspartame Really Safer on Risk to Induce Hypoglycemia During Exercise in Type 2 Diabetic Patients? Diabetes Care. 2007;30:59.
9. Poirier P, Tremblay A, Catellier C, Tancrède G, Garneau C, Nadeau A. Impact of Time Interval from the Last Meal on Glucose Response to Exercise in Subjects with Type 2 Diabetes. J Clin Endocrinol Metab. 2000;85:2860-4.
10. Brassard P, Ferland A, Bogaty P, Desmeules M, Jobin J, Poirier P. Influence of Glycemic Control on Pulmonary Function and Heart Rate in Response to Exercise in Subjects with Type 2 Diabetes Mellitus. Metabolism. 2006;55:1532-7.
11. Schmidt FH. Enzymatic Determination of Glucose and Fructose Simultaneously. Klin Wochenschr. 1961;39:1244-7.
12. Arnqvist H, Olsson PO, Von Schenck H. Free and Total Insulin as Determined after Precipitation with Polyethylene Glycol: Analytical Characteristics and Effects of Sample Handling and Storage. Clin Chem 1987;33:93-6.
13. Vyssoulis GP, Kouremetis MT, Valiouli MA, Michaelides AP, Toutouzas PK. Effect of Beta-Blockade on Exercise Capacity in Hypertensive Subjects: A One-Year Double-Blind Study of Celiprolol and Metoprolol. Cardiovasc Drugs Ther 1995;9:133-9.
14. Kendall MJ. Impact of Beta 1 Selectivity and Intrinsic Sympathomimetic Activity on Potential Unwanted Noncardiovascular Effects of Beta Blockers. Am J Cardiol 1987;59:44F-7F.